Precision Treatment: A Powerful Approach to Managing Advanced Prostate Cancer
Find Out If You’re a Candidate – Princeton
Fill out the form to schedule your personalized consultation.
By initiating a form fill, you’re consenting to be contacted with treatment information from United Theranostics.
Precision Treatment: A Powerful Approach to Managing Advanced Prostate Cancer
Targeted. Effective. Compassionate.
Pluvicto® represents a significant shift in the treatment of metastatic prostate cancer, and United Theranostics leverages its extensive experience to optimize the delivery of this targeted therapy. By precisely targeting PSMA-expressing cancer cells with radiation, Pluvicto® minimizes damage to healthy tissue and reduces side effects.
At our Princeton office, you’ll get:
- Cutting-edge radiopharmaceutical therapy
- Outpatient convenience with expert care
- Personalized treatment plans based on advanced PSMA imaging
- A supportive team that treats you like family
“United Theranostics gave me options that I didn’t even know I had.”
— Patient
How It Works – A Simple, Supportive Process
Getting started with Pluvicto therapy is easier than you think. Here’s what to expect:
Is Pluvicto Right for You?
You may be a candidate for Pluvicto if:
- You’ve been diagnosed with metastatic castration-resistant prostate cancer (mCRPC)
- You’ve previously undergone androgen receptor therapy or taxane-based chemotherapy
- Your cancer is PSMA-positive, confirmed through imaging
Even if you’re not sure, we invite you to schedule a consultation. Our Princeton team will work closely with you and your current doctors to help you explore all your options with clarity and compassion.
👉 Take the next step toward advanced, personalized care.
Frequently Asked Questions About Pluvicto Therapy
Is Pluvicto® a form of chemotherapy?
No. Pluvicto is a radiopharmaceutical therapy, not chemotherapy. It uses targeted radiation to attack cancer cells that express PSMA, while leaving most healthy tissue untouched. This often results in fewer side effects than traditional treatments.
What are the common side effects?
How do I know if I'm eligible for Pluvicto?
You may be eligible if you have metastatic castration-resistant prostate cancer (mCRPC), have previously been treated with androgen receptor therapy and/or chemotherapy, and your cancer tests positive for PSMA using a special PET scan. We’ll walk you through this step-by-step during your consult.
Will insurance cover Pluvicto therapy?
Many insurance plans, including Medicare, may cover all or part of your treatment. Our team will verify your benefits, handle pre-authorizations, and help you understand your options — including financial assistance programs, if needed.
Is it safe to be around my family after treatment?
Yes — with a few simple precautions. We’ll give you clear guidelines to reduce radiation exposure to others. For example, you may need to sleep separately or limit close contact with children or pregnant individuals for a few days after treatment.
Ready to Talk?
If you or a loved one is facing metastatic prostate cancer, you deserve clear answers, advanced options, and a care team that puts you first. Our Princeton specialists are here to help you explore whether Pluvicto® is the right step forward.
Don’t wait—your next chapter could start today.
👉 Schedule Your Consultation Now
Or call us directly at (640) 239-4900 to speak with our care team.
